Bilastine Impurity 35 | CAS 192775-97-6 - Request Quote
Bilastine Impurity 35
| SZ CAT No: | SZ-B034049 |
| CAS No | 192775-97-6 |
| Mol.F. | C14H18BrNO |
| Mol.Wt. | 296.2 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Bilastine Impurity 35 is chemically 2-(2-(4-Bromophenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole. Bilastine Impurity 35 is supplied with detailed characterization data compliant with regulatory guideline. Bilastine Impurity 35 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bilastine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 192775-97-6
Purchase 192775-97-6
Order 192775-97-6
Enquire 192775-97-6
price of 192775-97-6
192775-97-6 Supplier
192775-97-6 Manufacturer
192775-97-6 Exporter
buy high quality Bilastine Impurity 35
Purchase Bilastine Impurity 35
Bilastine Impurity 35 suppliers
Bilastine Impurity 35 manufacturers
Bilastine Impurity 35 price
Order Bilastine Impurity 35
Enquire Bilastine Impurity 35
Bilastine Impurity 35 cost
Bilastine Impurity 35 Supplier
Bilastine Impurity 35 Distributor
Bilastine Impurity 35 for Method Validation
Bilastine Reference Standard
Bilastine Impurity 35 for ANDA Filing
Bilastine Impurity 35 for Forced Degradation Studies
Bilastine Impurity 35 Identification Standards
Bilastine Impurity 35 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


